Point of Care Department Information - Revision history

Rwarwick: Removed PCR testing from Wairoa

2025-10-08T01:07:33Z

Removed PCR testing from Wairoa

← Older revision		Revision as of 01:07, 8 October 2025
Line 190:		Line 190:
	\|FBC		\|FBC
	\|Acute Ward, Laboratory		\|Acute Ward, Laboratory
	\|-
	~~\|Pluslife PCR~~
	~~\|Covid-19, Influenza A&B, RSV~~
	~~\|Acute Ward~~
	\|-		\|-
	\|Cobas B101		\|Cobas B101

Rwarwick: /* Hastings */

2025-02-26T21:07:01Z

Hastings

← Older revision		Revision as of 21:07, 26 February 2025
Line 148:		Line 148:
	\|Maternity		\|Maternity
	\|-		\|-
	\|Cobas ~~b101~~		\|Cobas B101
	\|HbA1c		\|HbA1c
	\|Diabetes Centre		\|Diabetes Centre
Line 155:		Line 155:
	\|Blood Gas		\|Blood Gas
	\|ICU		\|ICU
	\|-
	~~\|Credo VitaPCR~~
	~~\|Covid-19, Influenza A&B~~
	~~\|ED, Maternity and Ballantyne House~~
	\|-		\|-
	\|Siemens Clinitek		\|Siemens Clinitek
Line 195:		Line 191:
	\|Acute Ward, Laboratory		\|Acute Ward, Laboratory
	\|-		\|-
	\|~~Credo VitaPCR~~		\|Pluslife PCR
	\|Covid-19, Influenza A&B		\|Covid-19, Influenza A&B, RSV
			\|Acute Ward
			\|-
			\|Cobas B101
			\|C-reactive Protein
	\|Acute Ward		\|Acute Ward
	\|}		\|}
Line 236:		Line 236:
	\|Ketones		\|Ketones
	\|Bi-Monthly		\|Bi-Monthly
			\|-
			\|RCPA - Wairoa
			\|CRP
			\|Monthly
	\|-		\|-
	\|Waikato EQA - ED		\|Waikato EQA - ED
Line 241:		Line 245:
	\|Monthly		\|Monthly
	\|-		\|-
	\|Waikato EQA – Wairoa/Hastings		\|Waikato EQA – Wairoa/Hastings/CHB
	\|Glucose		\|Glucose
	\|Monthly		\|Monthly
Line 264:		Line 268:
	\|Blood Gas		\|Blood Gas
	\|Weekly		\|Weekly
			\|-
			\|Sample Comparison (Alinity vs B101)
			\|CRP
			\|Monthly
			\|-
			\|Sample Comparison (Alinity vs iSTAT)
			\|Chem8
			\|Monthly
	\|-		\|-
	\|RCPA sample comparison - CHB		\|RCPA sample comparison - CHB
	\|Troponin I		\|Troponin I
	~~\|Bi-Monthly~~
	\|-
	~~\|RCPA Rapid Molecular~~
	~~\|Covid-19, Influenza A&B~~
	\|Bi-Monthly		\|Bi-Monthly
	\|}		\|}
Line 323:		Line 331:
	\|Fortnightly		\|Fortnightly
	\|Anaesthetic Technicians		\|Anaesthetic Technicians
			\|-
			\|CRP
			\|Weekly
			\|Wairoa Laboratory Staff
	\|}		\|}

	All Internal and External QC is regularly reviewed and commented on by the POC QM and/or ~~relevant HOD/Senior Scientist~~ and acted upon if required.		All Internal and External QC is regularly reviewed and commented on by the POC QM and/or Chemical Pathologist and acted upon if required.

	== '''Out of Hours Support''': ==		== '''Out of Hours Support''': ==
	Wairoa For problems with POCT equipment on the ward after hours, consult with Associate Clinical Nurse Manager. If further support is required contact Wairoa Laboratory staff or POC QM.		Wairoa For problems with POCT equipment on the ward after hours, consult with Associate Clinical Nurse Manager. If further support is required contact Wairoa Laboratory staff or POC QM.

	Glucose /Ketones For problems with glucose meters out of hours contact the laboratory for a loan meter.		Glucose /Ketones For problems with glucose meters out of hours contact the laboratory for a loan meter.

	~~Lactate No out of hours support, send sample to the laboratory~~.

	~~Hemocue~~ No out of hours support, send sample to the laboratory.		Lactate No out of hours support, send sample to the laboratory.

	~~ABL90 ICU~~ No out of hours support, send sample to the laboratory.		Hemocue No out of hours support, send sample to the laboratory.

	~~Fetal Fibronection~~ No out of hours support.		ABL90 ICU No out of hours support, send sample to the laboratory.

	~~TEG~~ No out of hours support.		Fetal Fibronection No out of hours support.

	~~CHB,~~ ~~Not used~~ out of hours.		TEG No out of hours support.

	~~B101~~ Not used out of hours.		CHB Not used out of hours.

	~~Urinalysis~~ No out of hours support.		B101 No out of hours support.

	~~VitaPCR~~ No out of hours support~~. Send sample to the laboratory~~.		Urinalysis No out of hours support.

	== '''Equipment Inventory:''' ==		== '''Equipment Inventory:''' ==

Rwarwick at 23:29, 11 September 2023

2023-09-11T23:29:56Z

← Older revision		Revision as of 23:29, 11 September 2023
Line 144:		Line 144:
	\|Tech Room, Theatre		\|Tech Room, Theatre
	\|-		\|-
	\|~~Stat Strip~~ Lactate Meter, Fetal Fibronectin		\|Nova Lactate Meter, Fetal Fibronectin
	\|Lactate, FFN		\|Lactate, FFN
	\|Maternity		\|Maternity
Line 155:		Line 155:
	\|Blood Gas		\|Blood Gas
	\|ICU		\|ICU
			\|-
			\|Credo VitaPCR
			\|Covid-19, Influenza A&B
			\|ED, Maternity and Ballantyne House
			\|-
			\|Siemens Clinitek
			\|Urinalysis
			\|ED
	\|}		\|}

Line 186:		Line 194:
	\|FBC		\|FBC
	\|Acute Ward, Laboratory		\|Acute Ward, Laboratory
			\|-
			\|Credo VitaPCR
			\|Covid-19, Influenza A&B
			\|Acute Ward
	\|}		\|}

Line 224:		Line 236:
	\|Ketones		\|Ketones
	\|Bi-Monthly		\|Bi-Monthly
			\|-
			\|Waikato EQA - ED
			\|Urinalysis
			\|Monthly
	\|-		\|-
	\|Waikato EQA – Wairoa/Hastings		\|Waikato EQA – Wairoa/Hastings
Line 233:		Line 249:
	\|Weekly		\|Weekly
	\|-		\|-
	\|Sample Comparison (b101 ~~vrs~~ D100 Hastings)		\|Sample Comparison (b101 vs D100 Hastings)
	\|~~HbA<sub>1</sub>c~~		\|HbA1c
	\|Monthly		\|Monthly
	\|-		\|-
	\|Sample Comparison (meter ~~vrs~~ ABL Hastings)		\|Sample Comparison (meter vs ABL Hastings)
	\|Lactate		\|Lactate
	\|Monthly		\|Monthly
	\|-		\|-
	\|Sample Comparison (Hemocue ~~vrs~~ XN-3000)		\|Sample Comparison (Hemocue vs XN-3000)
	\|Haemoglobin		\|Haemoglobin
	\|Monthly		\|Monthly
	\|-		\|-
	\|Sample Comparison (~~ABL~~ Lab ~~vrs ABL~~ ICU)		\|Sample Comparison (ABL800 Lab vs ABL90 ICU)
	\|Blood Gas		\|Blood Gas
	\|Weekly		\|Weekly
Line 251:		Line 267:
	\|RCPA sample comparison - CHB		\|RCPA sample comparison - CHB
	\|Troponin I		\|Troponin I
			\|Bi-Monthly
			\|-
			\|RCPA Rapid Molecular
			\|Covid-19, Influenza A&B
	\|Bi-Monthly		\|Bi-Monthly
	\|}		\|}
Line 308:		Line 328:

	== '''Out of Hours Support''': ==		== '''Out of Hours Support''': ==
	Wairoa ~~For~~ problems with POCT equipment on the ward after hours, consult with Associate Clinical Nurse Manager. If further support is required contact Wairoa Laboratory staff or POC QM.		Wairoa For problems with POCT equipment on the ward after hours, consult with Associate Clinical Nurse Manager. If further support is required contact Wairoa Laboratory staff or POC QM.

	Glucose /Ketones For problems with glucose meters out of hours contact the laboratory for a loan meter.		Glucose /Ketones For problems with glucose meters out of hours contact the laboratory for a loan meter.

	Lactate No out of hours support, send sample to the laboratory.		Lactate No out of hours support, send sample to the laboratory.

	Hemocue No out of hours support, send sample to the laboratory.		Hemocue No out of hours support, send sample to the laboratory.

	ABL90 ICU No out of hours support, send sample to the laboratory.		ABL90 ICU No out of hours support, send sample to the laboratory.

	Fetal Fibronection No out of hours support.		Fetal Fibronection No out of hours support.

	TEG No out of hours ~~support~~.		TEG No out of hours support.

			CHB, Not used out of hours.

			B101 Not used out of hours.

	~~CHB, Not used~~ out of hours.		Urinalysis No out of hours support.

	~~B101 Not used~~ out of hours.		VitaPCR No out of hours support. Send sample to the laboratory.

	== '''Equipment Inventory:''' ==		== '''Equipment Inventory:''' ==
	All POC devices and instruments are documented and recorded on a spreadsheet located at:		All POC devices and instruments are documented and recorded on a spreadsheet located at:

	H:\Departments\Equipment Inventory\MASTER Equipment Inventory		J:\Departments\Equipment Inventory\MASTER Equipment Inventory

	Under the POC tab. This contains information relating to age of device, model, asset number and also hyperlinks to the individual devices Equipment Log. This log documents issues and troubleshooting.		Under the POC tab. This contains information relating to age of device, model, asset number and also hyperlinks to the individual devices Equipment Log. This log documents issues and troubleshooting.

Rwarwick: /* References */

2023-09-11T23:21:12Z

References

← Older revision		Revision as of 23:21, 11 September 2023
Line 95:		Line 95:

	== '''References''' ==		== '''References''' ==
	~~and for~~ detailed information on Point Of Care Testing requirements refer to:		For detailed information on Point Of Care Testing requirements refer to:

	HBDHB Point of Care Testing Policy HBDHB/CPG/101 (2020)		HBDHB Point of Care Testing Policy HBDHB/CPG/101 (2020)

	New Zealand Best Practice Guidelines for Point of Care Testing (~~2018~~)		New Zealand Best Practice Guidelines for Point of Care Testing (2022)


	The HBDHB POCT Manager (as appointed by the laboratory) is responsible for the implementation and maintenance of the POCT Quality Management System (QMS) for HBDHB clinical areas. The QMS is based ISO ~~22870~~:~~2006 and ISO 15189:2012~~, in line with IANZ accreditation requirements and national and international best practice. Refer to HBDHB POCT Policy CPG/SPG101 and relevant POCT Manuals for further information regarding the POCT QMS.		The HBDHB POCT Manager (as appointed by the laboratory) is responsible for the implementation and maintenance of the POCT Quality Management System (QMS) for HBDHB clinical areas. The QMS is based ISO 5189:2022, in line with IANZ accreditation requirements and national and international best practice. Refer to HBDHB POCT Policy CPG/SPG101 and relevant POCT Manuals for further information regarding the POCT QMS.

	== '''Point of Care Quality Manager Job Description''': ==		== '''Point of Care Quality Manager Job Description''': ==

Cgreenwo at 23:31, 4 August 2022

2022-08-04T23:31:36Z

← Older revision		Revision as of 23:31, 4 August 2022
Line 126:		Line 126:
	Wairoa I-STAT, poch-i100 and Lactate meter in the Acute Ward is owned by the Laboratory. There is no maintenance agreement for these instruments.		Wairoa I-STAT, poch-i100 and Lactate meter in the Acute Ward is owned by the Laboratory. There is no maintenance agreement for these instruments.

	=== '''Hastings''' ===		== '''Hastings''' ==
	{\| class="wikitable"		{\| class="wikitable"
	\|'''Equipment'''		\|'''Equipment'''
Line 155:		Line 155:
	\|Blood Gas		\|Blood Gas
	\|ICU		\|ICU
	\|}		\|}

	=== '''Wairoa''' ===		== '''Wairoa''' ==
	{\| class="wikitable"		{\| class="wikitable"
	\|'''Equipment'''		\|'''Equipment'''
Line 186:		Line 186:
	\|FBC		\|FBC
	\|Acute Ward, Laboratory		\|Acute Ward, Laboratory
	\|}		\|}

	=== '''Central Hawke’s Bay Health Centre (CHB)''' ===		== '''Central Hawke’s Bay Health Centre (CHB)''' ==
	{\| class="wikitable"		{\| class="wikitable"
	\|'''Equipment'''		\|'''Equipment'''
Line 201:		Line 201:
	\|Trop I		\|Trop I
	\|Laboratory		\|Laboratory
	\|}		\|}

	=== '''Quality Control''' ===		== '''Quality Control''' ==
	{\| class="wikitable"		{\| class="wikitable"
	\|'''EQA Programme'''		\|'''EQA Programme'''
Line 304:		Line 304:
	\|Anaesthetic Technicians		\|Anaesthetic Technicians
	\|}		\|}


	All Internal and External QC is regularly reviewed and commented on by the POC QM and/or relevant HOD/Senior Scientist and acted upon if required.		All Internal and External QC is regularly reviewed and commented on by the POC QM and/or relevant HOD/Senior Scientist and acted upon if required.

Cgreenwo: Created page with "== '''Definition: ''' == Point of Care Testing (POCT) is the performance by non-laboratory staff of an analytical test outside the conventional laboratory, at the site of or in the vicinity of the patient. == '''Devices: ''' == Devices for POCT testing range from basic dipsticks, to simple hand held devices such as glucose meters, through to complex analysers more commonly seen in a conventional laboratory, like blood gas analysers. == '''POCT Governance: ''' == La..."

2022-08-04T23:30:57Z

Created page with "== '''Definition: ''' == Point of Care Testing (POCT) is the performance by non-laboratory staff of an analytical test outside the conventional laboratory, at the site of or in the vicinity of the patient. == '''Devices: ''' == Devices for POCT testing range from basic dipsticks, to simple hand held devices such as glucose meters, through to complex analysers more commonly seen in a conventional laboratory, like blood gas analysers. == '''POCT Governance: ''' == La..."

New page

== '''Definition: ''' ==
Point of Care Testing (POCT) is the performance by non-laboratory staff of an analytical test outside the conventional laboratory, at the site of or in the vicinity of the patient.

== '''Devices: ''' ==
Devices for POCT testing range from basic dipsticks, to simple hand held devices such as glucose meters, through to complex analysers more commonly seen in a conventional laboratory, like blood gas analysers.

== '''POCT Governance: ''' ==
Laboratory Advisory Group also referred to as the POCT Committee.

== '''Benefits:''' ==
The use of Point of Care Testing may have a number of benefits for clinicians and patients. Thus POCT can be an important addition to laboratory-based analysis.

Benefits may include:

* improved turnaround time by shortening pre-analytical, analytical and post-analytical steps
* reduced therapeutic turnaround time
* improved monitoring of certain conditions where frequent testing is desirable such as diabetes and oral anticoagulant monitoring
* improved convenience and access to service e.g. for elderly patients
* smaller sample volumes which may be less invasive
* availability of rapid results to facilitate patient management
* opportunistic screening of the public for early identification of certain conditions
* ability to provide laboratory tests in remote locations or outside laboratory hours
* economic benefits may also be realised because although POCT testing is generally more expensive than conventional laboratory testing, POCT may offer economic benefits in terms of reduced clinic visits, length of hospital stay and hospital admissions

However, it should be noted that faster availability of results is only an advantage if the availability of results is the rate-limiting step in clinical care.

== '''Risks:''' ==
There are risks involved in the use of POCT devices, and therefore this testing should be limited to those circumstances where they are the only or the best solution to obtain test results when compared with testing in the central laboratory. Risks may include:

* POCT introduction without adequate investigation of clinical need
* inaccurate results due to lack of training or expertise, insufficient quality testing, or failure to recognise erroneous results, which may cause patient harm
* problems of comparability of results between different methods (laboratory versus POCT)
* increased costs due to additional instrumentation, expensive reagents, enrolment in external quality assurance programmes
* inadequate documentation of results and reporting
* increased workload for clinical staff
* the availability of arrays of screening tests which may result in inappropriate testing
* risks to patients as a result of implementation of non-performing devices or failure to recognise the limitations of POCT devices

To overcome the disadvantages requires significant resources and so careful consideration should be given to the clinical need before contemplating this type of testing. The advantages of POCT only hold true if the test result provided is accurate and reliable, and improves patient outcomes.

== '''Assessment of Clinical Need: ''' ==
In many cases improving the patient pathway and experience will be major considerations when introducing POCT. To be effective, POCT must deliver an equivalent level of quality and be at least as clinically effective as the alternative, and applied within the correct setting. These questions will help in assessing the clinical need for POCT:

* Does the current method of providing the service adequately meet the clinical need, and if it does not, what is the problem and can it be rectified?

* Is access to the laboratory a problem for patients, and can that be rectified?
* Which groups of patients need testing and what test(s) need to be performed?
* Will POCT enable more rapid or effective diagnosis, treatment or management?
* Will POCT provide a cost-effective alternative to laboratory testing?
* How would a POCT service compare to the current service in terms of quality?
* Would any change in quality be appropriate for best management of the patient?
* Can you provide evidence that POCT will provide a measurable clinical benefit

== '''Selection Criteria:''' ==
All new POCT devices or systems must undergo a rigorous evaluation procedure prior to their introduction. This will include a laboratory evaluation and may also include an on-site clinical evaluation.

For a candidate POCT device to be accepted the following criteria must be established:

* The results produced must be required for a rapid (urgent) clinical decision within a timescale that the central laboratory cannot achieve.
* The performance of the device and the results produced must consistently be of acceptable quality, and compatible with laboratory test ranges.
* The resource implications must be acceptable.
* The risks must be identified and manageable.
* There should be a strong evidence base for the test in question.

== '''Information Technology: ''' ==
All results obtained from POCT testing must be recorded and become part of the patient health record. Information technology (IT) capability can aid in minimising some of the potential sources of error in POCT testing and promote compliance with operator and patient identification procedures, test procedures and quality control requirements. Wherever possible, IT capable devices must be the selection of choice, and include software that:

* requires operator identification
* requires patient identification
* checks quality control
* transfers results directly to the patient record

Other desirable features which should be considered include:

* bidirectional data communication to allow patient data to be uploaded to the device, and results matched with patient information to be fed back to the information system
* access and data should be secure to ensure patient confidentiality
* ability to scan barcodes to facilitate accurate information entry, - operator ID, patient ID and lot numbers for consumables
* allow easy and regular monitoring of QC information to continually evaluate system performance

== '''Applications for POCT: ''' ==
In the first instance, application for new or additional POCT should be made to the POCT Quality Manager using the application form in Appendix 1 of the DHB policy. Once the application is passed on and approved by the Laboratory Committee, the POCT Quality Manager is responsible for the evaluation and recommendation of appropriate equipment in consultation with the Product Evaluation Committee.

== '''Financial Implications: ''' ==
The clinical areas installing POCT testing/devices are responsible for the costs of:

* The device
* The consumables
* Quality control material (QC)
* Enrolment and participation in external quality assurance programmes (EQA)
* Maintenance, repair and replacement
* An appropriate share of any connectivity costs and ongoing licence fees

Laboratory staff will have oversight of these activities, and provide guidance regarding suitable alternatives which must comply with laboratory IANZ accreditation requirements.

== '''References''' ==
and for detailed information on Point Of Care Testing requirements refer to:

HBDHB Point of Care Testing Policy    HBDHB/CPG/101 (2020)

New Zealand Best Practice Guidelines for Point of Care Testing (2018)

The HBDHB POCT Manager (as appointed by the laboratory) is responsible for the implementation and maintenance of the POCT Quality Management System (QMS) for HBDHB clinical areas. The QMS is based ISO 22870:2006 and ISO 15189:2012, in line with IANZ accreditation requirements and national and international best practice. Refer to HBDHB POCT Policy CPG/SPG101 and relevant POCT Manuals for further information regarding the POCT QMS.

== '''Point of Care Quality Manager Job Description''': ==

* Document, implement and maintain the POCT Quality Management System
* Be responsible for ensuring that all POCT is performed to an appropriate standard.
* Maintain a record of all POCT equipment within the HBDHB.
* Be responsible for ensuring that all POCT users have current competency training and documentation.
* Be responsible for ensuring regular quality assurance is maintained and quality control samples are analysed on POCT devices, with up to date documentation and history.
* Maintain (monitor) service records for each device.
* Be responsible for trouble shooting of POCT devices and overseeing the maintenance of up to date documentation and history.

Competency of users is undertaken annually and documented appropriately.

All methods manuals and associated POCT documents are also reviewed annually.

'''As a general rule all POCT equipment is owned, operated and funded by the clinical areas.'''

The exceptions to this are:

Wairoa I-STAT, poch-i100 and Lactate meter in the Acute Ward is owned by the Laboratory. There is no maintenance agreement for these instruments.

=== '''Hastings''' ===
{| class="wikitable"
|'''Equipment'''
|'''Tests'''
|'''Location'''
|-
|Nova Glucose Meters
|Glucose, Ketone
|Inpatient Wards, Radiology
|-
|Xpress Glucose Meters
|Glucose
|Villa’s (OPD), District Nurses incl Napier
|-
|Hemocue, CoaguChek, TEG
|Hgb, INR, TEG
|Tech Room, Theatre
|-
|Stat Strip Lactate Meter, Fetal Fibronectin
|Lactate, FFN
|Maternity
|-
|Cobas b101
|HbA1c
|Diabetes Centre
|-
|ABL90
|Blood Gas
|ICU
|}

=== '''Wairoa''' ===
{| class="wikitable"
|'''Equipment'''
|'''Test'''
|'''Location'''
|-
|Nova Glucose Meter
|Glucose, Ketones
|Acute Ward
|-
|Nova Lactate Meter
|Lactate
|Acute Ward, Laboratory
|-
|Nova Xpress Glucose Meter
|Glucose
|District Nurses
|-
|I-STAT
|UECG, Blood Gas, Trop I, INR
|Acute Ward, Laboratory
|-
|CoaguChek
|INR
|Laboratory
|-
|Pochi 100i
|FBC
|Acute Ward, Laboratory
|}

=== '''Central Hawke’s Bay Health Centre (CHB)''' ===
{| class="wikitable"
|'''Equipment'''
|'''Tests'''
|'''Location'''
|-
|Nova Glucose Meters
|Glucose, Ketones
|General Ward
|-
|I-STAT
|Trop I
|Laboratory
|}

=== '''Quality Control''' ===
{| class="wikitable"
|'''EQA Programme'''
|'''Test'''
|'''Frequency'''
|-
|RCPA –ICU ABL90
|Blood Gas
|Monthly
|-
|RCPA -Wairoa
|Blood Gas, Chem 8+, Troponin I
|Monthly
|-
|RCPA – Wairoa/Hastings
|INR
|Bi-Monthly
|-
|RCPA - Wairoa
|Ketones
|Bi-Monthly
|-
|Waikato EQA – Wairoa/Hastings
|Glucose
|Monthly
|-
|HB Labs Sample Swap - Wairoa
|FBC
|Weekly
|-
|Sample Comparison (b101 vrs D100 Hastings)
|HbA<sub>1</sub>c
|Monthly
|-
|Sample Comparison (meter vrs ABL Hastings)
|Lactate
|Monthly
|-
|Sample Comparison (Hemocue vrs XN-3000)
|Haemoglobin
|Monthly
|-
|Sample Comparison (ABL Lab vrs ABL ICU)
|Blood Gas
|Weekly
|-
|RCPA sample comparison - CHB
|Troponin I
|Bi-Monthly
|}

{| class="wikitable"
|'''Internal QC'''
|'''Frequency'''
|'''Performed by'''
|-
|ABL90
|3x Daily
|Analyser - automated
|-
|FBC
|Daily
|Wairoa Laboratory Staff
|-
|Nova Glucose & Ketone
|Daily
|Ward Staff
|-
|Nova Xpress Glucose
|Weekly
|District Nurses or HCA’s
|-
|I-STAT – electronic checks
|Daily (NOT required for Alinity)
|Wairoa/CHB
|-
|I-STAT – liquid QC
|Monthly or New lot number/Delivery
|Wairoa/CHB
|-
|Coaguchek
|Monthly or New lot number/Delivery
|Wairoa Laboratory Staff/ Anaesthetic Technician
|-
|Cobas b101
|Monthly or New lot number/Delivery
|Diabetes Clinic Staff Nurse
|-
|Hemocue
|Monthly or New lot number/Delivery
|Anaesthetic Technician
|-
|Lactate
|Weekly
|Wairoa/Maternity Staff
|-
|TEG
|Fortnightly
|Anaesthetic Technicians
|}

All Internal and External QC is regularly reviewed and commented on by the POC QM and/or relevant HOD/Senior Scientist and acted upon if required.

== '''Out of Hours Support''': ==
Wairoa For problems with POCT equipment on the ward after hours, consult with Associate Clinical Nurse Manager. If further support is required contact Wairoa Laboratory staff or POC QM.

Glucose /Ketones For problems with glucose meters out of hours contact the laboratory for a loan meter.

Lactate No out of hours support, send sample to the laboratory.

Hemocue    No out of hours support, send sample to the laboratory.

ABL90 ICU No out of hours support, send sample to the laboratory.

Fetal Fibronection No out of hours support.

TEG    No out of hours support.

CHB, Not used out of hours.

B101    Not used out of hours.

== '''Equipment Inventory:''' ==
All POC devices and instruments are documented and recorded on a spreadsheet located at:

H:\Departments\Equipment Inventory\MASTER Equipment Inventory

Under the POC tab. This contains information relating to age of device, model, asset number and also hyperlinks to the individual devices Equipment Log. This log documents issues and troubleshooting.